Without your more detailled explanation of what that term specifically
means I was wondering too at first.  But then I did the most obvious
thing: search for it online and found
https://scholar.google.com/scholar?q=%22in+silico+synthesis%22&hl=en&as_sdt=0&as_vis=1&oi=scholart
.  Looks to me other people use the term and in similar fashion as you
too

On Fri, 25 Sep 2020 at 06:21, Bennion, Brian via Rdkit-discuss
<rdkit-discuss@lists.sourceforge.net> wrote:
>
> hello
>
> I have a paper in review and is intended for a large audience that has 
> synthetic chemists, biologist and comp chem.
> One reviewer had issues with the term in-silico syntheses.
> I used rdkit and smarts reactions to generate large libraries of compounds 
> for our research project.  Is there a better term to use?  I feel "chemical 
> enumeration" is just as foreign.
>
> The abstract is below.
>
> The current standard treatment for organophosphate poisoning primarily relies 
> on the use of small molecule-based oximes that can efficiently restore 
> acetylcholinesterase (AChE) activity.  Despite their efficacy in reactivating 
> AChE, the action of drugs like 2-pralidoxime (2-PAM) is primarily limited to 
> the peripheral nervous system (PNS) and, thus, provides no protection to the 
> central nervous system (CNS).  This lack of action in the CNS stems from the 
> ionic nature of the drugs; they cannot cross the blood-brain barrier (BBB) to 
> access to any nerve agent-inhibited AChE therein.  In this report, we present 
> a small molecule oxime, called LLNL-02, that can diffuse across the BBB for 
> reactivation of nerve agent-inhibited AChE in the CNS.  Our 
> candidate-development approach utilizes a combination of parallel chemical 
> and in - silico syntheses, computational modeling, and a battery of detailed 
> in vitro and in vivo assessments that have identified LLNL-02 as a top 
> CNS-active candidate against nerve agent poisoning.   Additional experiments 
> to determine acute and chronic  toxicity as required for regulatory approval 
> are ongoing.
>
>
> _______________________________________________
> Rdkit-discuss mailing list
> Rdkit-discuss@lists.sourceforge.net
> https://lists.sourceforge.net/lists/listinfo/rdkit-discuss


_______________________________________________
Rdkit-discuss mailing list
Rdkit-discuss@lists.sourceforge.net
https://lists.sourceforge.net/lists/listinfo/rdkit-discuss

Reply via email to